Serenus Biotherapeutics
Privately held specialty biopharmaceutical company.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD235—352m (Dealroom.co estimates Mar 2015.)
San Francisco California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$43.0m | Late VC | ||
| Total Funding | CAD58.6m | ||
Related Content
Recent News about Serenus Biotherapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.